These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32681603)

  • 1. Early steroid withdrawal in HIV-infected kidney transplant recipients: Utilization and outcomes.
    Werbel WA; Bae S; Yu S; Al Ammary F; Segev DL; Durand CM
    Am J Transplant; 2021 Feb; 21(2):717-726. PubMed ID: 32681603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Steroid Withdrawal in Deceased-Donor Kidney Transplant Recipients with Delayed Graft Function.
    Bae S; Garonzik Wang JM; Massie AB; Jackson KR; McAdams-DeMarco MA; Brennan DC; Lentine KL; Coresh J; Segev DL
    J Am Soc Nephrol; 2020 Jan; 31(1):175-185. PubMed ID: 31852720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Mortality and Graft Loss With Kidney Retransplantation Among Human Immunodeficiency Virus (HIV)-Infected Recipients.
    Shelton BA; Mehta S; Sawinski D; Reed RD; MacLennan PA; Gustafson S; Segev DL; Locke JE
    Am J Transplant; 2017 Jan; 17(1):173-179. PubMed ID: 27305590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction Immunosuppression and Clinical Outcomes in Kidney Transplant Recipients Infected With Human Immunodeficiency Virus.
    Kucirka LM; Durand CM; Bae S; Avery RK; Locke JE; Orandi BJ; McAdams-DeMarco M; Grams ME; Segev DL
    Am J Transplant; 2016 Aug; 16(8):2368-76. PubMed ID: 27111897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial disparity in kidney transplant survival relates to late rejection and is independent of steroid withdrawal.
    Liu A; Woodside KJ; Augustine JJ; Sarabu N
    Clin Transplant; 2018 Sep; 32(9):e13381. PubMed ID: 30098053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inconsistencies in the association of clinical factors with the choice of early steroid withdrawal across kidney transplant centers: A national registry study.
    Bae S; Garonzik-Wang JM; Massie AB; McAdams-DeMarco MA; Coresh J; Segev DL
    Clin Transplant; 2021 Feb; 35(2):e14176. PubMed ID: 33259086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Panel-reactive Antibody and the Association of Early Steroid Withdrawal With Kidney Transplant Outcomes.
    Bae S; McAdams-DeMarco MA; Massie AB; Garonzik-Wang JM; Coresh J; Segev DL
    Transplantation; 2022 Mar; 106(3):648-656. PubMed ID: 33826598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Protease Inhibitor-Based Anti-Retroviral Therapy on Outcomes for HIV+ Kidney Transplant Recipients.
    Sawinski D; Shelton BA; Mehta S; Reed RD; MacLennan PA; Gustafson S; Segev DL; Locke JE
    Am J Transplant; 2017 Dec; 17(12):3114-3122. PubMed ID: 28696079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Optimal Donor-Recipient Combinations Among Human Immunodeficiency Virus (HIV)-Positive Kidney Transplant Recipients.
    Locke JE; Shelton BA; Reed RD; MacLennan PA; Mehta S; Sawinski D; Segev DL
    Am J Transplant; 2016 Aug; 16(8):2377-83. PubMed ID: 27140837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient and Graft Survival Outcomes During 2 Eras of Immunosuppression Protocols in Kidney Transplantation: Indiana University Retrospective Cohort Experience.
    Adebiyi O; Umukoro P; Sharfuddin A; Taber T; Chen J; Lane KA; Li X; Goggins W; Yaqub MS
    Transplant Proc; 2021 Dec; 53(10):2841-2852. PubMed ID: 34774307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Steroid Withdrawal in Recipients of a Kidney Transplant From a Living Donor: Experience of a Single Mexican Center.
    Andrade-Sierra J; Rojas-Campos E; Cardona-Muñoz E; Evangelista-Carrillo LA; Gómez-Navarro B; González-Espinoza E; Lugo-Lopez O; Cerrillos-Gutiérrez JI; Medina-Pérez M; Jalomo-Martínez B; Nieves-Hernández JJ; Sandoval M; Abundis-Jiménez JR; Ramírez-Robles JN; Villanueva-Pérez MA; Monteón-Ramos F; Cueto-Manzano AM
    Transplant Proc; 2016; 48(1):42-9. PubMed ID: 26915841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Belatacept-based immunosuppression with simultaneous calcineurin inhibitor avoidance and early corticosteroid withdrawal: A prospective, randomized multicenter trial.
    Woodle ES; Kaufman DB; Shields AR; Leone J; Matas A; Wiseman A; West-Thielke P; Sa T; King EC; Alloway RR;
    Am J Transplant; 2020 Apr; 20(4):1039-1055. PubMed ID: 31680394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol.
    Jaber JJ; Feustel PJ; Elbahloul O; Conti AD; Gallichio MH; Conti DJ
    Clin Transplant; 2007; 21(1):101-9. PubMed ID: 17302598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes in HIV+/HCV+ coinfected kidney transplant recipients in the pre- and post-direct-acting antiviral therapy eras: 10-Year single center experience.
    Camargo JF; Anjan S; Chin-Beckford N; Morris MI; Abbo LM; Simkins J; Ciancio G; Chen LJ; Burke GW; Figueiro J; Guerra G; Kupin WL; Mattiazzi A; Ortigosa-Goggins M; Ram Bhamidimarri K; Roth D
    Clin Transplant; 2019 May; 33(5):e13532. PubMed ID: 30866102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Leukocyte Antigen Mismatch and Steroid Maintenance in Kidney Transplantation.
    Chopra B; Sureshkumar KK
    Transplant Proc; 2015 Dec; 47(10):2852-4. PubMed ID: 26707301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Center-Level Experience and Kidney Transplant Outcomes in HIV-Infected Recipients.
    Locke JE; Reed RD; Mehta SG; Durand C; Mannon RB; MacLennan P; Shelton B; Martin MY; Qu H; Shewchuk R; Segev DL
    Am J Transplant; 2015 Aug; 15(8):2096-104. PubMed ID: 25773499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal transplantation in human immunodeficiency virus-infected recipients: a case-control study from the Brazilian experience.
    Vicari AR; Spuldaro F; Sandes-Freitas TV; Cristelli MP; Requião-Moura LR; Reusing JO; Pierrotti LC; Oliveira ML; Girão CM; Gadonski G; Kroth LV; Deboni LM; Ferreira GF; Tedesco-Silva H; Esmeraldo R; David-Neto E; Saitovitch D; Keitel E; Garcia VD; Pacheco-Silva A; Medina-Pestana JO; Manfro RC
    Transpl Infect Dis; 2016 Oct; 18(5):730-740. PubMed ID: 27503081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor-specific antibodies development in renal living-donor receptors: Effect of a single cohort.
    Andrade-Sierra J; Cueto-Manzano AM; Rojas-Campos E; Cardona-Muñoz E; Cerrillos-Gutiérrez JI; González-Espinoza E; Evangelista-Carrillo LA; Medina-Pérez M; Jalomo-Martínez B; Nieves Hernández J; Pazarín-Villaseñor L; Mendoza-Cerpa CA; Gómez-Navarro B; Miranda-Díaz AG
    Int J Immunopathol Pharmacol; 2021; 35():20587384211000545. PubMed ID: 33787382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppression regimen and the risk of acute rejection in HIV-infected kidney transplant recipients.
    Locke JE; James NT; Mannon RB; Mehta SG; Pappas PG; Baddley JW; Desai NM; Montgomery RA; Segev DL
    Transplantation; 2014 Feb; 97(4):446-50. PubMed ID: 24162248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early steroid withdrawal results in improved patient and graft survival and lower risk of post-transplant cardiovascular risk profiles: A single-center 10-year experience.
    Lopez-Soler RI; Chan R; Martinolich J; Park L; Ata A; Chandolias N; Conti DJ
    Clin Transplant; 2017 Feb; 31(2):. PubMed ID: 27888534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.